Es gab 46 kürzliche Insider-Transaktionen für Spyre Therapeutics, Inc. (SYRE), darunter 28 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $70.86M und die gesamten Insider-Verkäufe auf $8.01M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Turtle Cameron, Burrows Scott L, Sloan Sheldon. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SYRE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Turtle Cameron |
Chief Executive Officer |
Informierter Verkauf |
2,656 |
$49.92 |
$132.59K |
627,540 |
| 2026-04-01 |
Burrows Scott L |
Chief Financial Officer |
Informierter Verkauf |
1,300 |
$49.98 |
$64.97K |
97,994 |
| 2026-04-01 |
Sloan Sheldon |
Chief Medical Officer |
Informierter Verkauf |
7,958 |
$50.00 |
$397.9K |
- |
| 2026-03-03 |
Burrows Scott L |
Chief Financial Officer |
Informierter Verkauf |
200 |
$41.66 |
$8.33K |
97,994 |
| 2026-03-02 |
Turtle Cameron |
Chief Executive Officer |
Informierter Verkauf |
9,100 |
$42.49 |
$386.66K |
642,540 |
| 2026-02-02 |
Turtle Cameron |
Chief Executive Officer |
Informierter Verkauf |
14,043 |
$32.87 |
$461.59K |
657,540 |
| 2026-01-21 |
Henderson Michael Thomas |
Director |
Sonstige (Kauf) |
63,227 |
- |
- |
168,606 |
| 2026-01-09 |
Turtle Cameron |
Chief Executive Officer |
RSU-Zuteilung |
528,000 |
$30.61 |
$16.16M |
528,000 |
| 2026-01-09 |
King-jones Heidy |
See Remarks |
RSU-Zuteilung |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-09 |
Burrows Scott L |
Chief Financial Officer |
RSU-Zuteilung |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-09 |
Sloan Sheldon |
Chief Medical Officer |
RSU-Zuteilung |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-02 |
Turtle Cameron |
Chief Executive Officer |
Informierter Verkauf |
100 |
$32.39 |
$3.24K |
671,907 |
| 2025-12-01 |
Turtle Cameron |
Chief Executive Officer |
Informierter Verkauf |
4,005 |
$29.83 |
$119.47K |
686,907 |
| 2025-11-03 |
Turtle Cameron |
Chief Executive Officer |
Informierter Verkauf |
16,845 |
$23.66 |
$398.55K |
701,907 |
| 2025-09-02 |
Burrows Scott L |
Chief Financial Officer |
Informierter Verkauf |
18,428 |
$16.26 |
$299.64K |
97,994 |
| 2025-05-29 |
Albers Jeffrey W. |
Director |
RSU-Zuteilung |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Stelzer Laurie |
Director |
RSU-Zuteilung |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Mckenna Mark C. |
Director |
RSU-Zuteilung |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Henderson Michael Thomas |
Director |
RSU-Zuteilung |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Fairmount Funds Management Llc |
Director |
RSU-Zuteilung |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Milligan Sandra |
Director |
RSU-Zuteilung |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-01-15 |
Turtle Cameron |
Chief Executive Officer |
RSU-Zuteilung |
370,000 |
$21.66 |
$8.01M |
370,000 |
| 2025-01-15 |
King-jones Heidy |
See Remarks |
RSU-Zuteilung |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-15 |
Burrows Scott L |
Chief Financial Officer |
RSU-Zuteilung |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-15 |
Sloan Sheldon |
Chief Medical Officer |
RSU-Zuteilung |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-10 |
Henderson Michael Thomas |
Director |
Sonstige (Kauf) |
105,379 |
- |
- |
105,379 |
| 2024-11-06 |
Albers Jeffrey W. |
Director |
Informierter Verkauf |
6,700 |
$36.76 |
$246.31K |
27,360 |
| 2024-10-25 |
Albers Jeffrey W. |
Director |
Informierter Verkauf |
300 |
$36.43 |
$10.93K |
34,060 |
| 2024-10-01 |
Sloan Sheldon |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-01 |
Sloan Sheldon |
Chief Medical Officer |
RSU-Zuteilung |
400,000 |
$27.46 |
$10.98M |
400,000 |
| 2024-09-03 |
Burrows Scott L |
Chief Financial Officer |
Informierter Verkauf |
18,531 |
$28.17 |
$522.07K |
116,422 |
| 2024-05-14 |
Albers Jeffrey W. |
Director |
RSU-Zuteilung |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Stelzer Laurie |
Director |
RSU-Zuteilung |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Henderson Michael Thomas |
Director |
RSU-Zuteilung |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Fairmount Funds Management Llc |
Director |
RSU-Zuteilung |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Milligan Sandra |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-05-14 |
Milligan Sandra |
Director |
RSU-Zuteilung |
21,980 |
$39.29 |
$863.59K |
21,980 |
| 2024-04-25 |
Fairmount Funds Management Llc |
Director |
Optionsausübung (Verkauf) |
90,992 |
- |
- |
346,045 |
| 2024-02-15 |
Turtle Cameron |
Chief Executive Officer |
RSU-Zuteilung |
400 |
$9.82 |
$3.93K |
746,907 |
| 2024-02-01 |
Turtle Cameron |
Chief Executive Officer |
RSU-Zuteilung |
277,750 |
$25.86 |
$7.18M |
277,750 |
| 2024-02-01 |
King-jones Heidy |
See Remarks |
RSU-Zuteilung |
63,000 |
$25.86 |
$1.63M |
63,000 |
| 2024-02-01 |
Burrows Scott L |
Chief Financial Officer |
RSU-Zuteilung |
70,000 |
$25.86 |
$1.81M |
70,000 |
| 2024-02-01 |
Mckenna Mark C. |
Director |
Veräußerung |
477,000 |
$10.39 |
$4.96M |
- |
| 2024-02-01 |
Mckenna Mark C. |
Director |
RSU-Zuteilung |
40,000 |
$25.86 |
$1.03M |
40,000 |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
Sonstige (Verkauf) |
3,435,480 |
- |
- |
- |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
RSU-Zuteilung |
16,667 |
- |
- |
16,667 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
